Comera Life Sciences Inc. (CMRAW) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Comera Life Sciences Inc...

    NASDAQ: CMRAW · Real-Time Price · USD
    0.02
    null (null%)
    At close: Sep 17, 2024, 10:00 PM

    Comera Life Sciences Income Statement

    Financials in USD. Fiscal year is undefined.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2022 FY 2021
    Period Ending Dec 31, 2022 Dec 31, 2021
    Revenue
    		 633.1K 319.83K
    Cost of Revenue
    		 210.39K 161.01K
    Gross Profit
    		 422.71K 158.82K
    Operating Income
    		 -11.97M -5.54M
    Interest Income
    		 n/a n/a
    Pretax Income
    		 -18M -5.45M
    Net Income
    		 -18M -5.29M
    Selling & General & Admin
    		 10.65M 3.94M
    Research & Development
    		 1.74M 1.75M
    Other Expenses
    		 n/a -76.74K
    Operating Expenses
    		 12.39M 5.69M
    Interest Expense
    		 20.39K n/a
    Selling & Marketing Expenses
    		 n/a n/a
    Cost & Expenses
    		 12.6M 5.86M
    Income Tax Expense
    		 n/a -160.59K
    Shares Outstanding (Basic)
    		 10.45M 19.09M
    Shares Outstanding (Diluted)
    		 10.45M 19.09M
    EPS (Basic)
    		 -1.76 -0.28
    EPS (Diluted)
    		 -1.76 -0.28
    EBITDA
    		 -17.89M -5.36M
    EBIT
    		 -17.98M -5.45M
    Depreciation & Amortization
    		 93.95K 88.82K

    Add to Watchlist